National Institute of General Medical Sciences; Notice of Closed Meetings, 47121-47122 [2021-18047]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices
• November 10, 2021 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
All meetings are open to the public.
Additional meetings may be scheduled
as needed. For web conference
instructions and the most up-to-date
information, please visit the HITAC
calendar on the ONC website, https://
www.healthit.gov/topic/federaladvisory-committees/hitac-calendar.
Contact Person for Meetings: Michael
Berry, Michael.Berry@hhs.gov. A notice
in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Michael
Berry for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, and patient access. In addition,
the committee will also address any
administrative matters and hear
periodic reports from ONC. ONC
intends to make background material
Recommendations
available to the public no later than 24
The HITAC recommendations to the
hours prior to the meeting start time. If
National Coordinator are publicly
ONC is unable to post the background
available at https://www.healthit.gov/
material on its website prior to the
topic/federal-advisory-committees/
meeting, the material will be made
recommendations-national-coordinator- publicly available on ONC’s website
health-it.
after the meeting, at https://
www.healthit.gov/hitac.
Public Meetings
Procedure: Interested persons may
The schedule of meetings to be held
present data, information, or views,
in 2021 is as follows:
orally or in writing, on issues pending
• January 13, 2021 from approximately
before the committee. Written
9:30 a.m. to 2:30 p.m./Eastern Time
submissions may be made to the contact
(virtual meeting)
person prior to the meeting date. An
• February 10, 2021 from approximately oral public comment period will be
9:30 a.m. to 2:30 p.m./Eastern Time
scheduled at each meeting. Time
(virtual meeting)
allotted for each commenter will be
• March 10, 2021 from approximately
limited to three minutes. If the number
9:30 a.m. to 2:30 p.m./Eastern Time
of speakers requesting to comment is
(virtual meeting)
greater than can be reasonably
• April 15, 2021 from approximately
accommodated during the scheduled
9:30 a.m. to 2:30 p.m./Eastern Time
public comment period, ONC will take
(virtual meeting)
written comments after the meeting.
• May 13, 2021 from approximately
Persons attending in-person HITAC
9:30 a.m. to 2:30 p.m./Eastern Time
meetings are advised that the agency is
(virtual meeting)
• June 9, 2021 from approximately 9:30 not responsible for providing wireless
access or access to electrical outlets.
a.m. to 2:30 p.m./Eastern Time
ONC welcomes the attendance of the
(virtual meeting)
• July 14, 2021 from approximately 9:30 public at its HITAC meetings. Seating is
limited at in-person meetings, and ONC
a.m. to 2:30 p.m./Eastern Time
will make every effort to accommodate
(virtual meeting)
persons with physical disabilities or
• September 9, 2021 from
approximately 9:30 a.m. to 2:30 p.m./ special needs. If you require special
accommodations due to a disability,
Eastern Time (virtual meeting)
• October 13, 2021 from approximately please contact Michael Berry at least
seven (7) days in advance of the
9:30 a.m. to 2:30 p.m./Eastern Time
meeting.
(virtual meeting)
jbell on DSKJLSW7X2PROD with NOTICES
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives; and
• Other members are appointed by
the Comptroller General of the United
States.
Members will serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay,
but will be provided per-diem and
travel costs for committee services, if
warranted.
VerDate Sep<11>2014
18:11 Aug 20, 2021
Jkt 253001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
47121
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., App.
2).
Dated: July 27, 2021.
Michael Berry,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2021–18019 Filed 8–20–21; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Review of SuRE Applications.
Date: November 18, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Sonia Ortiz-Miranda,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, (301) 402–9448,
sonia.ortiz-miranda@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Review of SuRE Applications.
Date: November 19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Manas Chattopadhyay,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Building 45, Room 3AN12N, 45
Center Drive, Bethesda, MD 20892, 301–827–
5320, manasc@mail.nih.gov.
E:\FR\FM\23AUN1.SGM
23AUN1
47122
Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: August 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18047 Filed 8–20–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: September 14, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Soheyla Saadi, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E70A, Rockville, MD
20852, (240) 669–5178, saadisoh@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:11 Aug 20, 2021
Jkt 253001
Dated: August 17, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–17988 Filed 8–20–21; 8:45 am]
National Institute on Aging; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Fellowships in
Digestive Diseases and Nutrition.
Date: October 14–15, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Diabetes and
Digestive and Kidney Diseases, NIH, 6707
Democracy Boulevard, Room 7011, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Division of
Extramural Activities, NIDDK, NIH, Room
7011, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18040 Filed 8–20–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging, Initial Review Group; Career
Development for Established Investigators
and Conference Grants Study Section NIA–
AGCD–4.
Date: October 14, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Greg Bissonette, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, 301–402–1622, bissonettegb@
mail.nih.gov.
Name of Committee: National Institute on
Aging, Initial Review Group; Career
Development for Early Career Investigators
Study Section NIA–AGCD–2.
Date: October 14–15, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Carmen Moten, Ph.D.,
MPH Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg.,
2C212, 7201 Wisconsin Avenue, Bethesda,
MD 20814, 301–402–7703, cmoten@
mail.nih.gov.
Name of Committee: National Institute on
Aging, Initial Review Group; Career
Development Facilitating The Transition to
Independence Study Section NIA–AGCD–1.
Date: October 14–15, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Pages 47121-47122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18047]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; NIGMS Review of SuRE Applications.
Date: November 18, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Video Meeting).
Contact Person: Sonia Ortiz-Miranda, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN18, Bethesda, MD 20892, (301) 402-9448, [email protected].
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; NIGMS Review of SuRE Applications.
Date: November 19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Video Meeting).
Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Building 45, Room
3AN12N, 45 Center Drive, Bethesda, MD 20892, 301-827-5320,
[email protected].
[[Page 47122]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859, Biomedical Research and
Research Training, National Institutes of Health, HHS)
Dated: August 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18047 Filed 8-20-21; 8:45 am]
BILLING CODE 4140-01-P
